Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

AHIMA17: MACRA is ‘tremendous opportunity’ for HIM

While clinicians may be confused or frustrated with the Medicare Access and CHIP Reauthorization Act (MACRA), professionals in health information management should see it as “nothing but positive” and embrace it, according to Bonnie Cassidy, MPA, principal of advisory services at nThrive and former president and chair of the American Health Information Management Association (AHIMA).

Thumbnail

FDA seeks speedier approval of generics

Food and Drug Commissioner Scott Gottlieb, MD, said the agency will tackle rising prescription drug costs by encouraging development of generic versions of complex drugs and drug-device combinations.

CHIP deadline passes with no action from Congress

The Sept. 30 deadline to renew the Children’s Health Insurance Program (CHIP) has come and gone, leaving funding for the 9 million children it covers in doubt if federal funding isn’t restored within the next few months.

HHS Secretary to pay back $52K of $1M in total travel costs

HHS Secretary Tom Price, MD, has announced he’ll reimburse the federal government for using private charter flights after POLITICO investigations have found he racked up $1 million in publicly-funded travel costs. However, he’ll only pay back the cost of his seat on domestic charter flights, amounting to $52,000.

Thumbnail

Trump preparing order on selling health insurance across state lines

After another effort to repeal the Affordable Care Act (ACA) was halted, President Donald Trump told reporters he’ll likely sign an executive order regarding another one of his campaign promises on healthcare: allowing insurance plans to be offered across state lines.

Thumbnail

Healthcare groups tell Congress to move on ‘for good’ from ACA repeal

Major healthcare associations said they were relieved by Senate Republicans’ decision to table the Graham-Cassidy legislation to repeal the Affordable Care Act (ACA), bringing at least a temporary halt to the party’s efforts to replace the law with only Republican votes.

Thumbnail

Graham-Cassidy ACA repeal bill tabled: ‘We’re coming back to this’

Senate Republicans have decided not to vote on the Graham-Cassidy legislation to repeal the Affordable Care Act (ACA), putting an end to months of efforts to pass a repeal bill before a Sept. 30 deadline for it to clear the Senate with a simple majority.

Thumbnail

Graham-Cassidy bill gets a hearing, a CBO score—and another ‘no’ vote

Sept. 25 ended up being a rough day for supporters of the Graham-Cassidy legislation to repeal the Affordable Care Act (ACA), beginning with the bill’s only scheduled hearing being interrupted by protesters shouting, “No cuts to Medicaid, save our liberty.”

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup